By G HossainPosted on April 21, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Obesity-focused Kailera Therapeutics debuted on the Nasdaq Friday after raising a record $625 million, beating Moderna’s $600 million from 2018. UPDATE: Kailera breaks biotech IPO record with $625M debut Post navigation Viatris recalls extended-release Xanax over dissolution test failureLilly’s Foundayo reaches 1,390 patients in first week, trailing Novo’s oral Wegovy launch